Reforma del sector salud y la política farmacéutica en Perú

Abstract

This article analyzes the Shared Pharmaceutical Management Program (PACFARM) and its relationship to pharmaceutical policy in Peru within the scope of health sector reform. Implementation of various programs for essential medicines has involved an on-going effort towards improving the supply of essential drugs to the community. However, the corresponding legal framework includes random and disconnected regulations which hinder the feasibility of a consistent national drug policy. PACFARM is a decentralized system for the provision of essential medicines on a care-level basis, self-supported by revolving funds. While expanded coverage and decreased economic barriers to access to essential medicines provided the basis for a pharmaceutical policy and traits of supply management efficiency kept pace with administrative modernization as part of the reform, other aspects hindered the program's implementation and limited its effects, including deregulation and the very processes of change in the sector. The study's methodology included qualitative and quantitative techniques, prioritizing an analysis of the program's implementation.

Free access to hypertension and diabetes medicines among the elderly: a reality yet to be constructed

“…It is still a challenge to guarantee access to essential medicines, particularly in developing countries 9 . In 1998 the government approved the National Medicines Policy 10 , based on Pharmaceutical Assistance Reorientation, in an attempt to promote access to and the rational use of medicines, along with the adoption of the National Essential Medicines List (RENAME), a list of medicines considered basic and indispensable for most population health problems.…”

Implementación de la Política Nacional de Medicamentos de la Reforma de la Salud: percepción del profesional farmacéutico

“…En el mismo sentido, las fortalezas y debilidades identificadas en el presente estudio respecto del diseño e implementación de la Política Nacional de Medicamentos se han presentado en otras experiencias de reformas de la salud que han sido acompañadas con políticas farmacéuticas en el continente. En Perú, una de las principales fortalezas para la implementación de la política de medicamentos fue la voluntad de los actores de los distintos niveles de toma de decisiones del sector 20 . En el caso de la implementación de la Política en Chile, este aspecto fue reconocido como una debilidad en la implementación.…”

Pharmacies and the Pharmaceutical Industry in Latin America

“…Local clinic personnel and community representatives made final decisions on prices, fee-exemptions, and products offered. This program improved drug availability but not rational use (Phang Romero, 2002). In this country, community members often prefer brandname medicines to generics and pharmacy administrators tried to maximize the user fees to invest in the facility, equipment, and personnel (Álvarez-Risco, 2011).…”